Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results

Marinus Pharma (MRNS) Tops Q2 EPS by 4c

August 10, 2021 7:06 AM EDT

Marinus Pharma (NASDAQ: MRNS) reported Q2 EPS of ($0.65), $0.04 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $1.91 million versus the consensus estimate of $2.7 million.

For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.

... More